Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
February 15, 2024 - Page 4 of 4 - The Dermatology Digest
Search

First Patient Dosed in Artax’s Phase 2a Psoriasis Trial Evaluating AX-158

The first patient has been dosed in the Artax’s Phase 2a trial evaluating the safety and biomarker responses of AX-158 in a first proof of mechanism trial in psoriasis.  AX-158 has potential to be  the first immunomodulator in the Nck blocker class, the Company states. Safety and efficacy results are expected in second half of 2024. “The new Nck […]